GLP-1 Months 2–6: The Titration Phase
Dose escalation, what happens at each level, and why plateaus are part of the process.
The titration phase is where GLP-1 therapy actually starts working. Your starter dose was an introduction. Months 2 through 6 are the ramp-up — a carefully paced escalation designed to maximize weight loss while keeping side effects manageable.
Most providers follow the FDA-approved titration schedules, but the clinical reality involves judgment calls at every step. Here's what to expect at each dose level and how to work with your provider to find the right pace for your body.
The Titration Schedules
Key difference: Tirzepatide has more intermediate steps, giving providers greater flexibility to find a "minimum effective dose" — the lowest dose that produces meaningful results with tolerable side effects. Not every patient needs to reach the maximum.
What Happens at Each Dose Step
The First Increase (Month 2)
This is often when patients start feeling the medication's full impact. Appetite suppression becomes more pronounced. Nausea may return briefly as your body adjusts to the higher dose. The weight loss curve typically steepens here — expect 3–6 pounds in month two if you've tolerated the increase well.
Mid-Range Doses (Months 3–4)
The "sweet spot" for many patients. By semaglutide 1.0 mg or tirzepatide 7.5–10.0 mg, most people are experiencing significant appetite reduction, changed food preferences (many patients report losing interest in sugary or greasy foods), and steady weight loss of 1–2 pounds per week.
This is also when some patients plateau briefly. A week or two of no scale movement doesn't mean the medication has stopped working — body composition changes (fat loss concurrent with water retention) can mask progress. Measurements and how your clothes fit are often more reliable indicators than the scale alone.
Higher Doses (Months 5–6)
Not every patient reaches or needs the maximum dose. If you're losing weight steadily at a mid-range dose with manageable side effects, your provider may recommend staying there. The clinical goal is the "minimum effective dose" — enough to produce results without unnecessary side effects.
Pushing to the maximum dose when a lower dose is already working doesn't typically produce proportionally more weight loss. It does, however, increase the likelihood and severity of GI side effects.
Clinical trials use the maximum dose because they're testing peak efficacy. Real-world prescribing is more nuanced. A good provider will titrate based on your response, not a rigid schedule. If 1.7 mg semaglutide is working, you don't need 2.4 mg.
When Your Provider Should Hold a Dose
Titration isn't always a straight line up. Your provider should consider holding at the current dose (extending 4 weeks to 6 or 8 before increasing) if:
- You're experiencing persistent nausea or vomiting at the current dose
- You've lost significant weight rapidly (more than 1% of body weight per week for multiple weeks)
- You're struggling to meet minimum protein or calorie needs
- Lab work shows kidney function changes or electrolyte imbalances
- You're already seeing excellent results at the current dose
A provider who automatically increases your dose every 4 weeks regardless of how you're doing isn't practicing personalized medicine — they're following a script.
The Plateau Question
Almost every patient hits at least one plateau during months 2–6. A plateau means 2–3 weeks with no change on the scale despite consistent medication use and no significant dietary changes. Here's what's usually happening:
- Body recomposition. You may be losing fat while retaining water or gaining lean mass. Waist measurements often continue decreasing during scale plateaus.
- Metabolic adaptation. Your body adjusts its energy expenditure as you lose weight. This is normal and temporary.
- Dose response threshold. You may have hit the ceiling of what your current dose can do, signaling it's time for the next increase.
Plateaus are not failure. They're physiology. If a plateau persists beyond 4–6 weeks and you haven't reached the maximum dose, that's a conversation with your provider about dose adjustment.
Not every patient needs the maximum dose. Find a provider who adjusts to you.
MEDVi — Physician-Led GLP-1 Programs →Affiliate link. We earn commission at no cost to you.
The Bottom Line
Titration is a partnership between you and your provider. The schedule is a guideline, not a mandate. Communicate openly about side effects, energy levels, and how you're eating. A good provider will adjust the pace based on your experience — not just the calendar. The goal isn't to reach the maximum dose as fast as possible. It's to find the dose where you're losing weight steadily with side effects you can live with.